|
CA2681208A1
|
|
Method and means for preventing and inhibiting type iii secretion in infections caused by gram-negative bacteria
|
|
WO2006132583A1
|
|
Method and means for preventing and inhibiting respiratory disease, atherosclerosis and osteoporosis caused by chlamydia pneumoniae infection
|
|
EP1599601A1
|
|
Method for identification of novel virulence associated genes
|
|
AU2003256215A8
|
|
Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
|
|
WO0129087A1
|
|
Transcription factor-selective nuclear transport receptors required for immune response activation
|
